182 related articles for article (PubMed ID: 10668063)
1. Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report.
Pirl WF; Roth AJ
Psychooncology; 2000; 9(1):84-7. PubMed ID: 10668063
[No Abstract] [Full Text] [Related]
2. Olanzapine and serotonin toxicity.
Isbister GK; Downes F; Whyte IM
Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
[No Abstract] [Full Text] [Related]
3. Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.
DeRemer DL; Clemmons AB; Orr J; Clark SM; Gandhi AS
Pharmacotherapy; 2016 Feb; 36(2):218-29. PubMed ID: 26890915
[TBL] [Abstract][Full Text] [Related]
4. Can olanzapine be implicated in causing serotonin syndrome?
Haslett CD; Kumar S
Psychiatry Clin Neurosci; 2002 Oct; 56(5):533-5. PubMed ID: 12193243
[TBL] [Abstract][Full Text] [Related]
5. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
Melkersson K; Hulting AL
Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
[No Abstract] [Full Text] [Related]
6. [The change from clozapine to olanzapine--same effect?].
Pomp E
Tidsskr Nor Laegeforen; 2000 Mar; 120(8):945-6. PubMed ID: 10795501
[No Abstract] [Full Text] [Related]
7. Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.
Tyc VL; Mulhern RK; Fairclough D; Ward PM; Relling MV; Longmire W
J Dev Behav Pediatr; 1993 Aug; 14(4):236-41. PubMed ID: 8408666
[TBL] [Abstract][Full Text] [Related]
8. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
Weimer E; Braus DF; Cavus I; Thome J
Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
[TBL] [Abstract][Full Text] [Related]
9. [Hyperglycemia and ketoacidosis associated with olanzapine].
Von Hayek D; Hüttl V; Reiss J; Schweiger HD; Füessl HS
Nervenarzt; 1999 Sep; 70(9):836-7. PubMed ID: 10522253
[TBL] [Abstract][Full Text] [Related]
10. A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients.
Passik SD; Kirsh KL; Theobald DE; Dickerson P; Trowbridge R; Gray D; Beaver M; Comparet J; Brown J
J Pain Symptom Manage; 2003 May; 25(5):485-8. PubMed ID: 12727048
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
Srivastava M; Brito-Dellan N; Davis MP; Leach M; Lagman R
J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438
[TBL] [Abstract][Full Text] [Related]
12. Remission of cancer chemotherapy-induced emesis during antidepressant therapy with nefazodone.
Khouzam HR; Monteiro AJ; Gerken ME
Psychosom Med; 1998; 60(1):89-91. PubMed ID: 9492245
[TBL] [Abstract][Full Text] [Related]
13. Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report.
Aldurra G; Crayton JW
J Clin Psychopharmacol; 2001 Jun; 21(3):343-4. PubMed ID: 11386500
[No Abstract] [Full Text] [Related]
14. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
Weiss EL; Potenza MN; McDougle CJ; Epperson CN
J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
[TBL] [Abstract][Full Text] [Related]
15. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
Fonte C; Fatigoni S; Roila F
Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
Potenza MN; Wasylink S; Epperson CN; McDougle CJ
Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
[No Abstract] [Full Text] [Related]
17. The Benefits of Olanzapine in Palliating Symptoms.
Davis MP; Sanger GJ
Curr Treat Options Oncol; 2020 Nov; 22(1):5. PubMed ID: 33244634
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
Poyurovsky M; Kurs R; Weizman A
J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
[No Abstract] [Full Text] [Related]
19. Eosinophilia associated with olanzapine.
Mathias S; Schaaf LW; Sonntag A
J Clin Psychiatry; 2002 Mar; 63(3):246-7. PubMed ID: 11928731
[No Abstract] [Full Text] [Related]
20. Low-dose olanzapine for self-mutilation behavior in patients with borderline personality disorder.
Hough DW
J Clin Psychiatry; 2001 Apr; 62(4):296-7. PubMed ID: 11379847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
